AI Medical Technology Company AIRS Medical Secures $20 Million in Series C Funding
| | | | | |

AI Medical Technology Company AIRS Medical Secures $20 Million in Series C Funding

AI medical technology company, AIRS Medical, known for its pioneering work in artificial intelligence and robotics for healthcare applications, has successfully completed its Series C funding round, raising $20 million from seven institutional investors based in Korea. The funding will be utilized to support the companys flagship product, SwiftMR™, and further advance its mission of…

IntegriChain Acquires Federal Compliance Solutions to Enhance Pharmas Commercial Performance
| | |

IntegriChain Acquires Federal Compliance Solutions to Enhance Pharmas Commercial Performance

IntegriChain, a pharma technology company, has recently acquired Federal Compliance Solutions (FCS), a leading advisory and managed services firm in the pharma industry. This acquisition aims to bolster expertise in government pricing and payer/provider contracting to help pharmaceutical companies optimize their commercial performance in the face of mounting regulatory and commercial pressures on net revenue….

Vivo Infusion Acquires Infusion Associates, Expands Ambulatory Infusion Services
| |

Vivo Infusion Acquires Infusion Associates, Expands Ambulatory Infusion Services

Vivo Infusion, a leading provider of accessible and affordable ambulatory infusion services, has acquired Infusion Associates, an industry leader in ambulatory infusion services with centers in multiple states. The acquisition will bring Vivos total ambulatory infusion center count to nearly 80 across 15 states. Infusion Associates, founded in 2001, has established a unique operating model…

Dwight Capital and Dwight Mortgage Trust Finance $390.4 Million in Seniors Housing in Q2 2024
| | |

Dwight Capital and Dwight Mortgage Trust Finance $390.4 Million in Seniors Housing in Q2 2024

Dwight Capital and its affiliate REIT, Dwight Mortgage Trust (DMT), have successfully financed $390.4 million in seniors housing during the second quarter of 2024. The notable transactions included bridge loans for skilled nursing portfolios in various states, totaling significant bed numbers. DMT provided a $142 million bridge acquisition loan for a portfolio of ten skilled…

Quest Diagnostics to Acquire LifeLabs for Approximately CAN $1.35 Billion
| | |

Quest Diagnostics to Acquire LifeLabs for Approximately CAN $1.35 Billion

Quest Diagnostics, a leading provider of diagnostic information services, has announced a definitive agreement with OMERS to acquire LifeLabs, a trusted provider of community laboratory tests for Canadians, for approximately CAN $1.35 billion. The acquisition is aimed at accelerating growth and improving healthcare services in Canada. LifeLabs will retain its brand, Canadian headquarters, and management…

Iron Path Capital Fund I Exceeds Target, Closing at $273 Million
| |

Iron Path Capital Fund I Exceeds Target, Closing at $273 Million

Iron Path Capital Fund I has successfully closed at $273 million, surpassing its initial target of $250 million. The fund, led by Iron Path Capital, focuses on control investments in lowermiddle market specialty industrial and healthcare companies. The fund aims to partner with founders and managers to create transformative outcomes with the operational resources of…

Radionetics Oncology Announces Strategic Relationship with Eli Lilly and Company
| | | | |

Radionetics Oncology Announces Strategic Relationship with Eli Lilly and Company

Radionetics Oncology, a biotechnology company specializing in developing small molecule radiopharmaceuticals targeting G protein coupled receptors (GPCRs) for solid tumor treatment, has formed a strategic relationship with Eli Lilly and Company. The agreement includes an upfront cash payment of $140 million to Radionetics, with an option for Lilly to acquire Radionetics for $1 billion after…

Genezen Acquires uniQures Commercial Gene Therapy Operations
| | | |

Genezen Acquires uniQures Commercial Gene Therapy Operations

Genezen, a leading gene therapy CDMO, has announced the acquisition of uniQures commercial gene therapy operations in Lexington, MA. This strategic move will allow Genezen to expand its services globally, providing latephase and commercial gene therapy development and manufacturing services. The acquisition includes a stateoftheart viral vector manufacturing facility and a highly skilled team from…

Lee Equity Partners Announces Final Closing of Fund IV
| | |

Lee Equity Partners Announces Final Closing of Fund IV

Lee Equity Partners, LLC, a middlemarket private equity firm, recently closed Lee Equity Partners Fund IV, L.P., exceeding its target with total capital commitments of approximately $1.3 billion. The oversubscribed Fund IV attracted a diverse group of global investors, including family offices, pensions, sovereign wealth funds, and insurance companies. The firm has a history of…

CASI Pharmaceuticals Announces IND Application Submission and Preliminary Acquisition Proposal
| | | | |

CASI Pharmaceuticals Announces IND Application Submission and Preliminary Acquisition Proposal

CASI Pharmaceuticals, Inc., a biopharmaceutical company specializing in innovative therapeutic products, announced plans to submit an IND application to the FDA for CID103, a potential treatment for antibodymediated rejection in kidney transplant patients. The company intends to use the proceeds from a recent private placement financing to advance CID103 through Phase II clinical trials for…